References
- Stenman U-H, Huhtala M-L, Koistinen R, Seppälä M. Immunochemical demonstration of an ovarian cancer associated urinary peptide. Int J Cancer 1982; 30: 53–7
- Huhtala M-L, Pesonen K, Kalkkinen N, Stenman U-H. Purification and characterization of a tumor-associated trypsin inhibitor from the urine of a patient with ovarian cancer. J Biol Chem 1982; 257: 13713–6
- Halila H, Huhtala M-L, Schröder T, Kiviluoto T, Stenman U-H. Pancreatic secretory trypsin inhibitor in pancreatectomized patients. Clin Chim Acta 1985; 153: 209–16
- Matsuda K, Ogawa M, Murata A, Kitahara T, Kosaki G. Elevation of serum immunoreactive pancreatic secretory trypsin inhibitor contents in various malignant diseases. Res Commun Chem Pathol Pharmacol 1983; 40: 301–5
- Murata M, Ogawa M, Uda K-I, Matsuura N, Watanabe Y, Baba T, et al. Release of pancreatic secretory trypsin inhibitor from human hepatoblastoma cells on stimulation with cytokines. Life Sci 1988; 43: 1233–40
- Fielding J, Roginski C, Ellis D, et al. Clinico-pathological staging of cancer. Br J Surg 1984; 71: 677–80
- Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal type carcinoma. Acta Pathol Microbiol Scand 1975; 64: 31–49
- Lasson Å, Borgström A, Ohlsson K. Elevated pancreatic secretory trypsin inhibitor levels during severe inflammatory disease, renal insufficiency, and after various surgical procedures. Scand J Gastroenterol 1986; 21: 1275–80
- Matsuda K, Ogawa M, Shibata T, Nishibe S, Miyauchi K, Matsuda Y, Mori T. Postoperative elevation of serum pancreatic secretory trypsin inhibitor. Am J Gastroenterol 1985; 80: 694–8
- Ogawa M. Pancreatic secretory trypsin inhibitor as an acute phase reactant. Clin Biochem 1988; 21: 19–25
- McKeehan W L, Sakagami Y, Hoshi H, McKee-Han KA. Two apparent human endothelial cell growth factors from human hepatoma cells are tumor-associated proteinase inhibitors. J Biol Chem 1986; 261: 5378–83
- Stenman U-H. Tumour-associated trypsin inhibitor and tumour associated trypsin. Scand J Clin Lab Invest 1990; 50: 93–101, suppl 201